A. Boehmer (Rotterdam, Netherlands), F. De Benedictis (Ancona, Italy)
Peak bone mineral density (BMD) in children with asthma treated for a mean of 14 years with inhaled budesonide
S. Pedersen, L. Agertoft (Kolding, Denmark)
|  |
Inhaled ciclesonide is well-tolerated in children with persistent asthma: results from the rainbow study
S. Pedersen, C. Tiesler, R. Engelstätter, P. Potter, S. Dachev, J. Kaczmarek (Kolding, Denmark; Konstanz, Germany; Cape Town, South Africa; Ruse, Bulgaria; Lodz, Poland)
| |
Safety of omalizumab therapy in children with allergic asthma
H. Milgrom, A. Fowler-Taylor, C. Fernandez-Vidaurre, S. Jayawardene (Denver, East Hanover, United States Of America)
| |
Comparison of fluticasone propionate + salmeterol (FP+S) and montelukast (MK) on bronchial reactivity (BR), pulmonary function (PF) and clinical outcome in children with mild asthma
A. Teper, C. Kofman, S. Zaragoza, V. Rodriguez, S. Lubovich, C. Eguiguren, S. Fucile (Buenos Aires, Argentina)
|  |
Comparison of inhaled ciclesonide, fluticasone propinate and fluticasone propionate + salmeterol in maintaining asthma control
I. Mihatov Stefanovic, E. Verona, B. Cicak, R. Vrsalovic (Zagreb, Croatia)
| |
Attenuation of exercise-induced bronchoconstriction with montelukast or salmeterol added to inhaled fluticasone in children
S. S. Smugar, R. Fogel, N. Rosario, G. Aristizabal, T. Loeys, S. Gaile, G. P. Noonan, P. G. Polos (West Point, Rahway, United States Of America; Curitiba, Brazil; Bogota, Colombia)
| |
Ciclesonide dosing is effective for persistent paediatric asthma: the rainbow study
S. Pedersen, J. Dunkel, R. Engelstätter, P. Potter, S. Dachev, J. Kaczmarek (Kolding, Denmark; Konstanz, Germany; Cape Town, South Africa; Ruse, Bulgaria; Lodz, Poland)
| |
Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use
T. Bridges, J. Hébert, A. Fowler-Taylor, C. Fernandez-Vidaurre, I. Berhane (Albany, East Hanover, United States Of America; Quebec, Canada)
| |
Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma
S. Pedersen, S. Hirsch, R. Engelstätter, P. Potter, S. Dachev, J. Kaczmarek (Kolding, Denmark; Konstanz, Germany; Cape Town, South Africa; Ruse, Bulgaria; Lodz, Poland)
| |
Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction
S. S. Smugar, R. Fogel, G. Aristizabal, N. Rosario, T. Loeys, S. Gaile, G. P. Noonan, P. G. Polos (West Point, Rahway, United States Of America; Bogota, Colombia; Curitiba, Brazil)
| |
Combined inhaled corticosteroid and long acting β agonist treatment of paediatric asthma: experience of an asthma care programme
O. H. Teoh, J. Tang, O. M. Chay, A. Goh, L. Ho, W. C. Chiang, P. Wong (Singapore, Singapore)
| |
Population pharmacokinetic analysis of fluticasone propionate data from adult and pediatric subjects with asthma
R. Mehta, S. Yang, M. Beerahee (Reserach Triangle Park, United States Of America; Greenford, United Kingdom)
| |
Systemic activity of inhaled beclomethasone dipropionate HFA: a comparison of volume spacers
O. D. Wolthers, F. Sergio (Randers, Denmark; Parma, Italy)
| |
Body mass index in asthmatic children before and after 1 year inhaled glucocorticosteroids therapy
G. Kostic, N. Ilic, M. Petrovic, Z. Raskovic, V. Pavlovic, Z. Igrutinovic (Kragujevac, Vrsac, Republic Of Serbia)
| |
Additional overall benefit to coexistent asthma and rhinitis symptoms control in patients treated with leukotriene receptor antagonist
S. Pljaskic Kamenov, A. Kamenov, B. Kamenov, S. Cekic (Nis, Republic Of Serbia)
| |
Adherence to inhaled controller therapy and local adverse events in children with asthma
C. Gheonea, D. Plesca, L. Dumitrescu (Craiova, Bucharest, Romania)
| |
A small droplet size nebulizer is required for administration of di-sodium-cromo-glycate (DSCG), a still undervalued potent drug
M. Keller, H. Spescha, A. Moeller, N. Knauer, D. Inci, J. Wildhaber (Munich, Germany; Chur, Zuerich, Fribourg, Switzerland)
| |
Efficiency of fluticasone propinate with salmeterol in asthmatic children during 1 years
A. Stojkovic-Andjelkovic, D. Savic, A. Vujic, S. Obradovic, B. Vuletic, Z. Igrutinovic (Kragujevac, Republic Of Serbia)
| |
Quality of life in paediatric patients with asthma
R. Bodnár, A. Németh, A. Mészáros (Budapest, Hungary)
| |
Influence of a combination therapy versus steroid monotherapy on FeNO
C. Vogelberg, D. Aschmann, P. Barikbin, H. Mittenzwey, C. Würfel (Dresden, Germany)
| |